Drug Shortage Report for MYLAN-ABACAVIR/LAMIVUDINE
Report ID | 65420 |
Drug Identification Number | 02450682 |
Brand name | MYLAN-ABACAVIR/LAMIVUDINE |
Common or Proper name | ABACAVIR/LAMIVUDINE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ABACAVIR LAMIVUDINE |
Strength(s) | 600MG 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BL |
ATC code | J05AR |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2018-09-04 |
Actual start date | 2018-09-04 |
Estimated end date | 2019-02-15 |
Actual end date | 2019-02-15 |
Shortage status | Resolved |
Updated date | 2019-02-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-02-16 | English | Compare |
v8 | 2019-02-15 | French | Compare |
v7 | 2019-02-15 | English | Compare |
v6 | 2019-01-30 | French | Compare |
v5 | 2019-01-30 | English | Compare |
v4 | 2018-11-20 | French | Compare |
v3 | 2018-11-20 | English | Compare |
v2 | 2018-10-23 | French | Compare |
v1 | 2018-10-23 | English | Compare |
Showing 1 to 9 of 9